$OKUR 4 SEC Filings

Filed On	Filing
23 Sep 2026	Form 4: Leverone Jason A., Chief Financial Officer Sold 302 shares ($898)
23 Sep 2026	Form 4: Saccomano Nicholas A, Director Sold 87 shares ($259)
11 Aug 2026	Form 4: Mathers Edward T, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Ratcliffe Liam, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Phillips Andrew John, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Manke Isaac, Director Granted 315,300 Stock Option (right to buy) · Disposed of 15,300 Stock Option (right to buy) (Disposition to Issuer)
11 Aug 2026	Form 4: Jansen Valerie Malyvanh, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Grey Michael G, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Carruthers R Michael, Director Granted 22,350 Stock Option (right to buy)
11 Aug 2026	Form 4: Saccomano Nicholas A, Director Granted 721,423 Employee Stock Option (right to buy) · Disposed of 571,423 Employee Stock Option (right to buy) (Disposition to Issuer)
11 Aug 2026	Form 4: Leverone Jason A., Chief Financial Officer Granted 185,933 Employee Stock Option (right to buy) · Disposed of 5,781 Employee Stock Option (right to buy (Disposition to Issuer) · Granted 5,781 Employee Stock Option (right to buy · 1 more
11 Aug 2026	Form 4: Hartley Dylan, Chief Scientific Officer Granted 187,603 Employee Stock Option (right to buy) · Disposed of 137,603 Employee Stock Option (right to buy) (Disposition to Issuer)
11 Aug 2026	Form 4: Agresta Samuel, Chief Medical Officer Granted 199,984 Employee Stock Option (right to buy) · Disposed of 149,984 Employee Stock Option (right to buy) (Disposition to Issuer)
24 Jun 2026	Form 4: Saccomano Nicholas A, Director Sold 86 shares ($378)
24 Jun 2026	Form 4: Leverone Jason A., Chief Financial Officer Sold 303 shares ($1.33K)
08 Jun 2026	Form 4: Mathers Edward T, Director Granted 7,650 Stock Option (right to buy)
08 Jun 2026	Form 4: Ratcliffe Liam, Director Granted 1,275 Stock Option (right to buy)
08 Jun 2026	Form 4: Phillips Andrew John, Director Granted 7,650 Stock Option (right to buy)
08 Jun 2026	Form 4: Jansen Valerie Malyvanh, Director Granted 7,650 Stock Option (right to buy)
08 Jun 2026	Form 4: Grey Michael G, Director Granted 7,650 Stock Option (right to buy)

Comments